DRUG INFORMATION ASSOCIATION INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1964

Legal Domicile

Principal Officer

MARWAN FATHALLAH

Phone

2154426100

Tax Period

2024-01-01 to 2024-12-31

DRUG INFORMATION ASSOCIATION INC, founded in 1964, is a mid-sized nonprofit in the Health Care sector that reported $20.0M in total revenue in fiscal year 2024. Revenue decreased 9% compared to the prior year. Expenses of $22.1M exceeded revenue, resulting in a 10% operating deficit.

Mission

DRUG INFORMATION ASSOCIATION, INC. ("DIA") FOSTERS INNOVATION TO IMPROVE HEALTH AND WELLBEING WORLDWIDE BY: - PROVIDING INVALUABLE FORUMS TO EXCHANGE VITAL INFORMATION AND DISCUSS CURRENT ISSUES RELATED TO HEALTH PRODUCTS, TECHNOLOGIES, AND SERVICES; - DELIVERING CUSTOMIZED LEARNING EXPERIENCES;- BUILDING, MAINTAINING, AND FACILITATING TRUSTED RELATIONSHIPS WITH AND AMONG INDIVIDUALS AND ORGANIZATIONS THAT DRIVE AND SHARE DIA VALUES AND MANDATES; AND - OFFERING A MULTIDISCIPLINARY NEUTRAL ENVIRONMENT, RESPECTED GLOBALLY FOR INTEGRITY AND RELEVANCY.

Program Service Accomplishments

Program 1

Expenses: $12,663,759 Revenue: $14,997,922

IN 2024 DIA HELD MORE THAN 135 MEETINGS AND WORKSHOPS WORLDWIDE, DIA ATTRACTED OVER 26,000 PARTICIPANTS TO MEETINGS AND WORKSHOPS IN THE UNITED STATES, EUROPE, CHINA, JAPAN AND INDIA.AMONG THESE...

IN 2024 DIA HELD MORE THAN 135 MEETINGS AND WORKSHOPS WORLDWIDE, DIA ATTRACTED OVER 26,000 PARTICIPANTS TO MEETINGS AND WORKSHOPS IN THE UNITED STATES, EUROPE, CHINA, JAPAN AND INDIA.AMONG THESE EVENTS, THE DIA GLOBAL ANNUAL MEETING, THE LEADING GLOBAL CONFERENCE ON PHARMACEUTICAL INFORMATION AND EDUCATION, ATTRACTED OVER 4,094 PARTICIPANTS FROM THE US AND ACROSS THE WORLD. THE DIA EUROPEAN ANNUAL MEETING, WHICH IS RECOGNIZED AS ONE OF THE PREMIER FORUMS FOR THE EXCHANGE OF INFORMATION IN THE EUROPEAN MEDICAL/PHARMACEUTICAL COMMUNITY, ATTRACTED 1,153 PARTICIPANTS.

Program 2

Expenses: $1,927,920 Revenue: $2,283,271

LEARNING: WITH AN ON-GOING COMMITMENT TO INTERNET TECHNOLOGY-BASED LEARNING, DIA CONTINUED TO EXPAND ITS GLOBAL REACH AND ADVANCE ITS MISSION BY OFFERING VARIOUS LEARNING OPPORTUNITIES IN ELECTRONIC FORMAT. IN 2024, DIA HAD 1,900 E-LEARNERS INCLUDING BOTH INDIVIDUALS AND GROUPS. IN ADDITION, THERE WERE 77 TRAINING COURSES HELD GLOBALLY WITH 2,283 PARTICIPANTS TRAINED THROUGH THESE TRAINING COURSES.

Program 3

Expenses: $1,104,564 Revenue: $1,308,155

DIA MEMBERSHIP: DIA PROVIDES PROGRAMS TO DEVELOP, STRENGTHEN, AND SUPPORT COLLABORATION WITH POLICY MAKERS, INDUSTRY REPRESENTATIVES, PUBLIC HEALTH AUTHORITIES, ACADEMIA AND OTHER HEALTHCARE...

DIA MEMBERSHIP: DIA PROVIDES PROGRAMS TO DEVELOP, STRENGTHEN, AND SUPPORT COLLABORATION WITH POLICY MAKERS, INDUSTRY REPRESENTATIVES, PUBLIC HEALTH AUTHORITIES, ACADEMIA AND OTHER HEALTHCARE STAKEHOLDERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $6,278

Program Service Revenue $19,358,468

Investment Income $586,383

Other Revenue $20,768

TOTAL REVENUE $19,971,897

Expense Breakdown

Grants Paid $0

Salaries & Benefits $11,396,611

Fundraising Expenses $0

Program Expenses $16,345,663

Other Expenses $10,661,827

TOTAL EXPENSES $22,058,438

Year-over-Year Comparison

	2024	2023	Change
Revenue	$19,971,897	$21,940,328	-0.1%
Expenses	$22,058,438	$23,019,356	0.0%
Net Income	$-2,086,541	$-1,079,028	+0.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

2500

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,440,779

Total Directors

$1,028,729

Key Employees

$2,065,206

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MARWAN FATHALLAH	PRESIDENT & CHIEF EXECUTIVE OFFICER	40.00	Officer Director	$986,809	$41,920	$1,028,729
KIHITO TAKAHASHI	CHAIR	2.50	Officer Director	$0	$0	$0
MICHAEL ROSENBLATT	IMMEDIATE PAST CHAIR	2.50	Officer Director	$0	$0	$0
CYNTHIA VERST	IMMEDIATE PAST CHAIR (UNTIL 06/24)	2.50	Officer Director	$0	$0	$0
TATYANA KOSHELEVA	TREASURER/SECRETARY	2.50	Officer Director	$0	$0	$0
CHOCKALINGAM PALANIAPPAN	DIRECTOR	1.25	Director	$0	$0	$0
JASON MONTELEONE	DIRECTOR	1.25	Director	$0	$0	$0
JUNAID BAJWA	DIRECTOR	1.25	Director	$0	$0	$0
PETER HONIG	DIRECTOR	1.25	Director	$0	$0	$0
PETER RONCO	DIRECTOR	1.25	Director	$0	$0	$0
PETER SORGER	DIRECTOR	1.25	Director	$0	$0	$0
ZILI LI	DIRECTOR	1.25	Director	$0	$0	$0
DAVID MUKANGA	DIRECTOR	1.25	Director	$0	$0	$0
RACHEL ZHANG	DIRECTOR/INCOMING CHAIR	1.25	Director	$0	$0	$0
FRANK JIANG	DIRECTOR (UNTIL 06/24)	1.25	Director	$0	$0	$0
JENS GRUEGER	DIRECTOR (UNTIL 06/24)	1.25	Director	$0	$0	$0
JACK FOSTER	CHIEF FINANCIAL OFFICER	40.00	Officer	$380,306	$31,744	$412,050
ANNA MCDERMOTT-VITAK	SVP/MNGING DIR AMER (UNTIL 7/24)	40.00	Key Emp	$241,447	$18,490	$259,937
ANIA MITAN	SVP/MD, EMEAIS	40.00	Key Emp	$392,269	$0	$392,269
CARIE PIERCE	SVP, GROWTH	40.00	Key Emp	$331,219	$19,503	$350,722
TIM HESS	GLOBAL HEAD OF BUSINESS & DIGITAL TECH.	40.00	Key Emp	$289,456	$28,661	$318,117
KATIE HILL	SVP/MD, GLOBAL PRODUCTS & PROF. EDUCATION	40.00	Key Emp	$267,391	$17,119	$284,510
KATIE TRUONG	SVP/MD, AMERICAS & GLOBAL HEAD OF BUSINESS OPS.	40.00	Key Emp	$251,260	$15,177	$266,437
MARIA VASSILEVA	CHIEF SCIENCE & REGULATORY OFFICER	40.00	Key Emp	$167,622	$25,592	$193,214
WELLINGTON CARRANZA	DIRECTOR, PMO & BUSINESS EXCELLENCE	40.00	Highest	$205,422	$7,896	$213,318
GREG SMITH	SENIOR DIRECTOR, FINANCE & ACCOUNTING	40.00	Highest	$204,706	$32,477	$237,183
JENNIFER ANDREE-WEBB	DIRECTOR, LEARNING & CONTINUING EDUCATION	40.00	Highest	$180,936	$38,846	$219,782
LINDA HEE JUNG KO	ASSOC. DIR., BUSINESS DEV.	40.00	Highest	$177,563	$32,185	$209,748
PEDRO BARROCA	ASSOC. DIR., OPERATIONS TRANSFORMATION	40.00	Highest	$168,804	$0	$168,804

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$19,971,897	$22,058,438	$22,590,311	$-2,086,541
2023	$21,940,328	$23,019,356	$23,691,852	$-1,079,028
2022	$19,858,774	$22,321,024	$24,485,219	$-2,462,250
2021	$18,932,810	$17,344,895	$19,118,250	$1,587,915
2020	$18,905,794	$19,022,854	$19,738,468	$-117,060
2019	$24,142,037	$24,015,187	$15,523,543	$126,850
2018	$23,614,037	$23,456,733	$14,815,950	$157,304